Alterity Therapeutics Ltd SEC filings PRNAF
Alterity Therapeutics Ltd has 1,000 filings in SEC EDGAR's recent list, going back to Oct 22, 2007. Its latest annual report, Form 20-F, was filed on Aug 28, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 25, 2023 | — |
| CORRESP | Letter to the SEC | Oct 23, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2023 | — |
| EFFECT | Filing | Jan 6, 2021 | — |
| CORRESP | Letter to the SEC | Jan 4, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2020 | — |
| EFFECT | Filing | Nov 23, 2020 | — |
| CORRESP | Letter to the SEC | Nov 19, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| EFFECT | Filing | Oct 9, 2020 | — |
| CORRESP | Letter to the SEC | Oct 8, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2020 | — |
| EFFECT | Filing | May 21, 2019 | — |
| CORRESP | Letter to the SEC | May 17, 2019 | — |
| UPLOAD | Letter from the SEC | May 16, 2019 | — |
| EFFECT | Filing | Oct 20, 2017 | — |
| CORRESP | Letter to the SEC | Oct 19, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2017 | — |
| EFFECT | Filing | Nov 10, 2014 | — |
| NT 20-F | Fye 6/30/14 | Oct 31, 2014 | Oct 31, 2014 |
| EFFECT | Filing | Jul 24, 2014 | — |
| EFFECT | Filing | May 31, 2011 | — |
| EFFECT | Filing | Apr 21, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2010 | — |
| CORRESP | Letter to the SEC | Apr 16, 2010 | — |
| CORRESP | Letter to the SEC | Apr 8, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2010 | — |
| EFFECT | Filing | Oct 5, 2009 | — |
| EFFECT | Filing | Aug 5, 2009 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2009 | — |
| CORRESP | Letter to the SEC | Jun 17, 2009 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2009 | — |
| CORRESP | Letter to the SEC | Apr 6, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2009 | — |
| CORRESP | Letter to the SEC | Mar 5, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2009 | — |
| EFFECT | Filing | Mar 10, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2008 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATHE (Nasdaq), PRNAF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1131343
- Former names
- PRANA BIOTECHNOLOGY LTD (until Apr 8, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.